SCHEMBL30582608

SCHEMBL30582608

CNc1ccc(-c2c(C3=CCC4(CCNCC4)CC3)n(C)c3ncnc(N)c23)cn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNT1 O60563 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ ITK Q08881 1/20 0.34
▸ RET P07949 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ PRMT5 O14744 12/20 0.32
▸ METTL3 Q86U44 10/20 0.32
▸ WDR77 Q9BQA1 3/20 0.32
▸ PIK3CD O00329 2/20 0.31
▸ ABL1 P00519 2/20 0.31
▸ EGFR P00533 2/20 0.31
▸ HCK P08631 2/20 0.31
▸ SRC P12931 2/20 0.31
▸ KDR P35968 2/20 0.31
▸ PIK3CA P42336 2/20 0.31
▸ PIK3CB P42338 2/20 0.31
▸ MTOR P42345 2/20 0.31
▸ PIK3CG P48736 2/20 0.31
▸ EPHB4 P54760 2/20 0.31
▸ PRKDC P78527 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26105963 1.00 CCNT1 (0.34) CCNT1CDK9ITKRETLRRK2
SCHEMBL31219399 0.86 MAP4K4 (0.33) RETLRRK2PRMT5METTL3WDR77
SCHEMBL26106044 0.85 CCNT1 (0.38) CCNT1CDK9RETLRRK2PIK3CD
SCHEMBL30582605 0.85 CCNT1 (0.38) CCNT1CDK9RETLRRK2PIK3CD
SCHEMBL26105782 0.85 PIK3CD (0.40) CCNT1CDK9RETLRRK2PIK3CD
SCHEMBL30582601 0.85 PIK3CD (0.40) CCNT1CDK9RETLRRK2PIK3CD
SCHEMBL26106008 0.84 ITK (0.35) ITKRETLRRK2EGFR
SCHEMBL26587873 0.84 ITK (0.49) ITKEGFR
SCHEMBL30582593 0.84 KCNH2 (0.34) CCNT1CDK9ABL1EGFRSRC
SCHEMBL30582590 0.84 KCNH2 (0.34) CCNT1CDK9ABL1EGFRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499616-A1 SPIROBICYCLIC COMPOUNDS Acerand Therapeutics (Hong Kong) Limited (HK) 2025-02-05 — — EP disclosed
CN-119013260-A Spirobicyclic compounds 优领医药科技(香港)有限公司 2024-11-22 — — CN disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback